Prune
Biotech

Pfizer drops another early cancer candidate from Seagen

The decision to scrap the ADC was made for “business reasons” and “was not related to any safety concerns or requests from regulatory authorities.”
Darren Incorvaia Mar 19, 2026 12:56pm
Diabetes obesity weight loss

Lilly triple-G bet sees 16.8% weight loss in ph. 3 diabetes test

Mar 19, 2026 6:45am
Shutterstock 244923752png

Stop asking for an AI strategy: 3 questions clinical leaders should ask instead

Brought to you by Syneos Health
MPS Families Carry Coffin to FDA

Rare disease advocates stage 'funeral' at FDA, make 4 demands

Mar 18, 2026 5:25pm
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
AstraZeneca
Favicon Fierce Pharma

AZ to build cell therapy supply hub, R&D center in Shanghai

Mar 19, 2026 10:20am
More News

Syneos Health scoops up Chinese CRO

Mar 19, 2026 11:00am

Phage-focused BiomX reset may include defense sector pivot

Mar 19, 2026 11:00am

MiniMed claims FDA clearance for small, screen-free insulin pump

Mar 19, 2026 10:40am

Lilly partner sees weight loss potential in hibernating animals

Mar 19, 2026 10:00am